Krebs Biochemicals and Industries Ltd
Returns vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD
Insufficient Data
Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company
Stock doesn't offer attractive dividend returns
Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock
Good time to consider, as stock is not in overbought zone
Red Flags FoundASM and GSM lists are measures to safeguard investors against volatility and unjustified stock prices. Pledging holdings means taking loans against held promoter shares. Stocks in ASM/GSM list or with high pledged promoter holding should be handled with caution. Unsolicited tips are sometimes circulated to manipulate the market. Beware of these stocks
Stock in ASM list
Krebs Biochemicals and Industries Ltd
KREBSBIO
Price Chart
Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Insufficient Data
Returns vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD
Insufficient Data
Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company
Stock doesn't offer attractive dividend returns
Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock
Good time to consider, as stock is not in overbought zone
Red Flags FoundASM and GSM lists are measures to safeguard investors against volatility and unjustified stock prices. Pledging holdings means taking loans against held promoter shares. Stocks in ASM/GSM list or with high pledged promoter holding should be handled with caution. Unsolicited tips are sometimes circulated to manipulate the market. Beware of these stocks
Stock in ASM list
Key Metrics
Forecast & RatingsDetailed Forecast
Price
Price Upside
—
Earnings
Earnings Growth
—
Revenue
Rev. Growth
—
Company Profile
Krebs Biochemicals and Industries Limited is engaged in the business of manufacture of active pharmaceutical ingredients. The Company is producing a number of pain killers, anti-asthmatic and anti-human immunodeficiency virus (HIV) drugs.
PeersCompare with peers
Sun Pharmaceutical Industries Ltd
Dr Reddy's Laboratories Ltd
Cipla Ltd
Gland Pharma Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Holdings TrendDetailed holdings
Increased Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has increased by 2.71%
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Recent NewsAll news
See all news
Recent EventsAll events
Shareholders meeting
Krebs Biochemicals and Industries Limited has submitted the Exchange a copy Srutinizers report of Extraordinary General Meeting held on November 29, 2021. Further, the company has informed the Exchange regarding voting results. | Download
Krebs Biochemicals and Industries Limited has submitted the Exchange a copy Srutinizers report of Extraordinary General Meeting held on November 29, 2021. Further, the company has informed the Exchange regarding voting results. | Download
Shareholders meeting
Krebs Biochemicals and Industries Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on November 29, 2021.Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, please find enclosed the summary of proceedings of the Extra Ordinary General Meeting (EGM) of the Company held on Monday, November 29 2021 through Video Conference / Other Audio-Visual Means.Further Mrs. Krithika Sharma, Practicing Company Secretary is the Scrutinizer for the remote e- voting and voting process carried out at the EGM.The voting results on the resolutions shall be declared on or before 1st December, 2021, along with scrutinizer s report and the same shall be placed on the Company s website at www.krebsbiochem.com and on the website of Kfintech Technologies Private Limited at www.kfintech.com and shall also be communicated to the Stock Exchanges where the shares of the Company are listed. | Download
Krebs Biochemicals and Industries Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on November 29, 2021.Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, please find enclosed the summary of proceedings of the Extra Ordinary General Meeting (EGM) of the Company held on Monday, November 29 2021 through Video Conference / Other Audio-Visual Means.Further Mrs. Krithika Sharma, Practicing Company Secretary is the Scrutinizer for the remote e- voting and voting process carried out at the EGM.The voting results on the resolutions shall be declared on or before 1st December, 2021, along with scrutinizer s report and the same shall be placed on the Company s website at www.krebsbiochem.com and on the website of Kfintech Technologies Private Limited at www.kfintech.com and shall also be communicated to the Stock Exchanges where the shares of the Company are listed. | Download
Reply to Clarification Sought
KREBSBIO: The Exchange had sought clarification from Krebs Biochemicals and Industries Limited with respect to announcement dated 30-Jul-2021, regarding board meeting held on July 30, 2021. On basis of above the Company was required to clarify following: 1. Disclosure of relationships between directors (in case of appointment of a director); 2. Provide confirmation in compliance with SEBI Letter dated June 14, 2018 read alongwith NSE Circular dated June 20, 2018.ￂﾠThe response of the Company is attached. | Download
KREBSBIO: The Exchange had sought clarification from Krebs Biochemicals and Industries Limited with respect to announcement dated 30-Jul-2021, regarding board meeting held on July 30, 2021. On basis of above the Company was required to clarify following: 1. Disclosure of relationships between directors (in case of appointment of a director); 2. Provide confirmation in compliance with SEBI Letter dated June 14, 2018 read alongwith NSE Circular dated June 20, 2018.ￂﾠThe response of the Company is attached. | Download
Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Insufficient Data